Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Noble

Showing results (411-420 of 434) with videos related to

Pageof 44
Sort By:
Iscience|June 21, 2021
Categorization of lung mesenchymal cells in development and fibrosisXue Liu, Simon C Rowan, Jiurong Liang, et al.
BMJ Open Respiratory Research|February 3, 2016
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trialsLisa Lancaster, Carlo Albera, Williamson Z Bradford, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary FibrosisWaldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
Transplantation|September 17, 2021
Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts MortalityS Samuel Weigt, Grace-Hyun J Kim, Heather D Jones, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Phosphatidylcholine Metabolism Controls Alveolar Progenitor Renewal and Pulmonary FibrosisAnas Rabata, Yujie Qiao, Weini Li, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Science Translational Medicine|June 14, 2019
Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosisYoon Mee Yang, Mazen Noureddin, Cheng Liu, et al.
JCI Insight|August 9, 2019
Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesiclesTanyalak Parimon, Changfu Yao, David M Habiel, et al.
Science (New York, N.Y.)|February 22, 2024
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneysShikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2021
The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantationMichael Y Shino, Qiuheng Zhang, Ning Li, et al.
Pageof 44

Showing results (411-420 of 434) with videos related to

Sort By:
Pageof 44
Iscience|June 21, 2021
Categorization of lung mesenchymal cells in development and fibrosisXue Liu, Simon C Rowan, Jiurong Liang, et al.
BMJ Open Respiratory Research|February 3, 2016
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trialsLisa Lancaster, Carlo Albera, Williamson Z Bradford, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary FibrosisWaldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
Transplantation|September 17, 2021
Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts MortalityS Samuel Weigt, Grace-Hyun J Kim, Heather D Jones, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Phosphatidylcholine Metabolism Controls Alveolar Progenitor Renewal and Pulmonary FibrosisAnas Rabata, Yujie Qiao, Weini Li, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Science Translational Medicine|June 14, 2019
Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosisYoon Mee Yang, Mazen Noureddin, Cheng Liu, et al.
JCI Insight|August 9, 2019
Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesiclesTanyalak Parimon, Changfu Yao, David M Habiel, et al.
Science (New York, N.Y.)|February 22, 2024
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneysShikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2021
The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantationMichael Y Shino, Qiuheng Zhang, Ning Li, et al.
Pageof 44